Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] Committed to the development of the pharmaceutical industry and human

Genertec China Meheco is a listed company (stock code: 600056) controlled by Genertec Group, an important central enterprise directly managed by the central government. It is one of the three major pharmaceutical enterprises among central enterprises. Its predecessor was the China National Medicines & Health Products Import & Export Corporation, established in 1983, and it joined Genertec Group in 1999.
China Meheco has complete pharmaceutical production bases and a well-established market terminal network. In recent years, the company has preliminarily established an integrated industrial pattern of trade, industry, technology, and service, with pharmaceutical and medical device commerce as the engine and pharmaceutical industry as the support. Its industrial forms cover the entire industrial chain, including planting and processing, R&D, production, sales, logistics, import and export trade, academic promotion, and technical services. It focuses on serving the construction of "Healthy China" and serving people's better lives, striving to become a trustworthy comprehensive service provider for pharmaceuticals and medical devices. According to authoritative industry rankings, the company ranked 50th among chemical pharmaceutical enterprises in the 2021 China Pharmaceutical Industry Top 100 list; the China Meheco-Chongqing Pharmaceutical consortium ranked 5th in the 2021 pharmaceutical distribution top 100.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

China Meheco Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

China Meheco How Fast Is Hiring Growing? (61 open positions)

Manage
Note: How fast is hiring at China Meheco Health Industry Co., Ltd. growing? China Meheco2025: 82 openings (up 215%), 2024: 26 openings (down 63%), 2023: 70 openings (down 1%), 2022: 71 openings (down 25%), 2021: 95 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

China Meheco Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at China Meheco Health Industry Co., Ltd. growing? China MehecoMaster's recruitment over the years: 2025: 4 openings (up 215%), 2022: 2 openings (down 25%), 2021: 2 openings.

China Meheco Doctoral Degree Job Demand Analysis

(More)
+2800%
Growth Rate
2026 vs 2025
China Meheco Doctoral Hiring by Year: 2026 — 28 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at China Meheco Health Industry Co., Ltd. growing? China MehecoDoctorate recruitment over the years: 2026: 29 openings (up 109%), 2025: 1 openings (up 215%), 2023: 1 openings (down 1%).

China Meheco R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at China Meheco Health Industry Co., Ltd.? Based on an analysis of China Meheco's job postings over the past year, "医疗卫生/美容保健类" demand: 19.5%, "生物/制药/化工/环保类": 19%, "其他(研发和技术类)": 14.6%, "科研类": 10.2%, "计算机/网络/技术类": 6.8%, "机械/仪器仪表类": 1%. For reference only.

China Meheco — What Are the Salaries Like? (205 records)

Manage
salary range: 4.5K - 50K, 64.3% of roles pay ¥20-50K
Note: salary statistics are based on 205 salary records from the past year and depend on the job sample. For reference only.
How is the salary at China Meheco Health Industry Co., Ltd.?China Meheco64.3% of positions earn 20-50K, Fresh graduate salary: ¥17.9K。经营管理类 average salary ¥34.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of China Meheco

(More)
Are salaries high at China Meheco Health Industry Co., Ltd.? We provide: 财务,副总,运营,研究员,bd,研发员,预算管理,医药研发,科学家,薪酬绩效,采购,业务发展,人事,医疗器械,总经理,税务,管理部经理,综合管理,临床,产品注册. Click to view detailed salary analysis by job.

China Meheco honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

China Meheco Related Industry Tags

Job Category

  • 经营管理类
    30.2% of total 30.2%
  • 医疗卫生/美容保健类
    19.5% of total 19.5%
  • 生物/制药/化工/环保类
    19% of total 19%
  • 财务/审计/统计类
    15.6% of total 15.6%

Education

  • 本科
    68.8% of total 68.8%
  • 博士
    14.1% of total 14.1%
  • 硕士
    13.2% of total 13.2%
  • 大专
    2.9% of total 2.9%

Experience

  • 5-10年
    53.7% of total 53.7%
  • 3-5年
    24.9% of total 24.9%
  • 1-3年
    8.3% of total 8.3%
  • 不限
    6.8% of total 6.8%
View Detailed Analysis

What does China Meheco Health Industry Co., Ltd. require? Who is China Meheco hiring? China Meheco recruitment: 经营管理类占比最多占30.2%,其次是医疗卫生/美容保健类占19.5%. What education can get in at China Meheco? 本科占比最多占68.8%,其次是博士占14.1%. High education required at China Meheco? 博士占14.1%,硕士占13.2%. Work experience required at China Meheco? 5-10年占比最多占53.7%,其次是3-5年占24.9%. Where are the job locations at China Meheco? 北京占比最多占65.9%,其次是海口占6.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 149,587.9748万(元)
Legal Representative: 杨光
Date Established:
Credit Code: 911100001000265317
Registered Address: 北京市丰台区西营街1号院1区1号楼25-28层

Partners & Suppliers

中国医药下属器械公司为碧迪医疗科技(江苏)代理部分产品。 Source
供应商 经销商/分销商
战略合作涵盖产品开发、市场拓展、供应链协同等多个维度 Source
供应商 多肽药物战略合作
中国医药前五大客户,调拨与代理业务合作紧密 Source
合作客户 医药分销客户
中国医药核心商业客户,主要负责北京及周边地区的药品分销 Source
合作客户 医药分销客户
中国医药前五大客户,药品分销网络的重要节点 Source
合作客户 医药分销客户

People who follow China Meheco also follow

China Meheco Competitors (Similar Companies)

“一家拥有70余年辉煌历史的制药企业”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Large pharmaceutical and health industry group”
“Large-scale pharmaceutical distribution enterprise”
“Dedicated to the research and development of molecularly targeted drug”
“A key state-owned backbone enterprise directly managed by the central ”
“Providing first-class solutions for global new energy applications”
“Products for the diagnosis and treatment of allergic diseases”
“A high-tech enterprise specializing in the research, development, prod”
“Although the processing is complicated, we dare not save labor; althou”
“The core platform of Sinopharm's Traditional Chinese Medicine industry”
“Continuously innovating to bring patients medicines that significantly”
“A landmark enterprise in the modernization of traditional Chinese medi”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Large pharmaceutical group”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates